المؤلفون: Tabernero, Josep, Yoshino, Takayuki, Stintzing, Sebastian, de Gramont, Aimery, Gibbs, Peter, Jonker, Derek J., Nygren, Peter, Papadimitriou, Christos, Prager, Gerald W., Tell, Roger, Lenz, Heinz-Josef

المصدر: Cancer Research Communications. 4(1):28-37

وصف الملف: electronic

URL الوصول: https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-527983
https://doi.org/10.1158/2767-9764.CRC-23-0361
https://uu.diva-portal.org/smash/get/diva2:1858137/FULLTEXT01.pdf

المؤلفون: de Gramont, Jérôme

المصدر: L'évidence perdue : Atelier philosophique 1. 2023, p. 284.

الاتاحة: https://www.cairn.info/l evidence perdue--9791037022653.htm

المؤلفون: de Gramont, Jérôme

المصدر: Comprendre: Revista catalana de filosofia; Vol. 19, Núm. 2 (2017): Monogràfic Filosofia francesa contemporània i Cristianisme; p. 9-30

مصطلحات موضوعية: Filosofia, Jean-Louis Chrétien, Christianisme, Henry Maldiney, Parole, Phenomenologie

وصف الملف: application/pdf

Relation: https://www.raco.cat/index.php/Comprendre/article/view/328839/419438

URL الوصول: https://www.raco.cat/index.php/Comprendre/article/view/328839

المؤلفون: DE GRAMONT, JÉRÔME

المصدر: Revista Portuguesa de Filosofia, 2023 Jan 01. 79(4), 1643-1660.

URL الوصول: https://www.jstor.org/stable/27312066

المؤلفون: de Gramont, Jérôme

المصدر: Le commencement à venir. 2022, p. 220.

الاتاحة: https://www.cairn.info/le-commencement-a-venir--9791037019646.htm

المؤلفون: Karapetis, C S, Liu, H, Sorich, M J, Pederson, L D, Van Cutsem, E, Maughan, T, Douillard, J Y, O'Callaghan, C J, Jonker, D, Bokemeyer, C, Sobrero, A, Cremolini, C, Chibaudel, B, Zalcberg, J, Adams, R, Buyse, M, Peeters, M, Yoshino, T, de Gramont, A, Shi, Q

المساهمون: Karapetis, C S, Liu, H, Sorich, M J, Pederson, L D, Van Cutsem, E, Maughan, T, Douillard, J Y, O'Callaghan, C J, Jonker, D, Bokemeyer, C, Sobrero, A, Cremolini, C, Chibaudel, B, Zalcberg, J, Adams, R, Buyse, M, Peeters, M, Yoshino, T, de Gramont, A, Shi, Q

مصطلحات موضوعية: Colon cancer, Prognostic markers, Targeted therapies

Relation: info:eu-repo/semantics/altIdentifier/pmid/38402342; info:eu-repo/semantics/altIdentifier/wos/WOS:001173229000001; volume:130; issue:8; firstpage:1269; lastpage:1278; numberofpages:10; journal:BRITISH JOURNAL OF CANCER; https://hdl.handle.net/11568/1233267; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85187309197; https://www.nature.com/articles/s41416-024-02604-y

الاتاحة: https://hdl.handle.net/11568/1233267
https://doi.org/10.1038/s41416-024-02604-y
https://www.nature.com/articles/s41416-024-02604-y

المؤلفون: Marijon, Hélène, Gery, Sigal, Chang, Hua, Landesman, Yosef, Shacham, Sharon, Lee, Dhong Hyun, de Gramont, Aimery, Koeffler, Harold Phillip

المصدر: Oncotarget. 12(18)

مصطلحات موضوعية: Breast Cancer, Genetics, Cancer, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, BRCA1, XPO1, olaparib, selinexor, triple negative breast cancer, Oncology and Carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/3hb126p3
https://escholarship.org/content/qt3hb126p3/qt3hb126p3.pdf

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_4_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942929

الاتاحة: https://doi.org/10.1158/2767-9764.24942929.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_4_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942929

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_9_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942914

الاتاحة: https://doi.org/10.1158/2767-9764.24942914.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_9_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942914

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_2_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942935

الاتاحة: https://doi.org/10.1158/2767-9764.24942935.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_2_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942935

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_3_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942932

الاتاحة: https://doi.org/10.1158/2767-9764.24942932.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_3_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942932

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_8_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942917

الاتاحة: https://doi.org/10.1158/2767-9764.24942917.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_8_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942917

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_5_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942926

الاتاحة: https://doi.org/10.1158/2767-9764.24942926.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_5_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942926

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_6_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942923

الاتاحة: https://doi.org/10.1158/2767-9764.24942923.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_6_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942923

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_13_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942944

الاتاحة: https://doi.org/10.1158/2767-9764.24942944.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_13_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942944

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Table_7_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942920

الاتاحة: https://doi.org/10.1158/2767-9764.24942920.v1
https://figshare.com/articles/journal_contribution/Supplementary_Table_7_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942920

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_7_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942959

الاتاحة: https://doi.org/10.1158/2767-9764.24942959.v1
https://figshare.com/articles/journal_contribution/Supplementary_Figure_7_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942959

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942968

الاتاحة: https://doi.org/10.1158/2767-9764.24942968.v1
https://figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942968

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942965

الاتاحة: https://doi.org/10.1158/2767-9764.24942965.v1
https://figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942965

المؤلفون: Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J. Jonker, Peter Nygren, Christos Papadimitriou, Gerald W. Prager, Roger Tell, Heinz-Josef Lenz

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Therapeutic Research and Development, Clinical Research and Trials, Biomarkers, Chemotherapy, Clinical-Stage Research, Gastrointestinal Cancers, Colorectal cancer, Pharmacology, Precision Medicine, Translational Research, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942971

الاتاحة: https://doi.org/10.1158/2767-9764.24942971.v1
https://figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_A_Randomized_Phase_III_Study_of_Arfolitixorin_versus_Leucovorin_with_5-Fluorouracil_Oxaliplatin_and_Bevacizumab_for_First-Line_Treatment_of_Metastatic_Colorectal_Cancer_The_AGENT_Trial/24942971